Fecal transplants yield positive outcomes for C. diff infection, study says | Study supports targeted testing for gastric adenocarcinoma | Study ties HCV drug to renal dysfunction in HIV/HCV patients
April 1, 2015
CONNECT WITH ACG®  FacebookTwitter
ACG SmartBrief
ACG SmartBrief is an official publication of the ACG.

Clinical Updates
Fecal transplants yield positive outcomes for C. diff infection, study says
Fecal transplants can successfully treat Clostridium difficile infection, University of Minnesota researchers report. The small study showed that patients undergoing fecal transplants had healthy changes in intestinal bacteria for as long as 21 weeks after the procedure. HealthDay News (3/30)
Share: LinkedInTwitterFacebookGoogle+Email
Study supports targeted testing for gastric adenocarcinoma
A serum pepsinogen level test given to male smokers at age 50 was effective in predicting which patients may develop gastric adenocarcinoma, researchers reported. The study found that targeted screening for this patient group would reduce lifetime risks of gastric adenocarcinoma by 30.8%, compared with risk reductions of 25.5% for endoscopy and 0.1% for H. pylori screening. Medscape (free registration) (3/30)
Share: LinkedInTwitterFacebookGoogle+Email
Study ties HCV drug to renal dysfunction in HIV/HCV patients
A 24-patient study showed that the use of telaprevir was associated with temporary renal dysfunction in patients infected with both HIV and hepatitis C virus. Estimated glomerular filtration rate was significantly reduced while patients were on the medication but returned almost to baseline rates after the drug was stopped. Medscape (free registration)/Reuters Health (3/31)
Share: LinkedInTwitterFacebookGoogle+Email
Report: Mortality rates decrease for colon, stomach cancers
Deaths related to some major cancers, including colon and stomach cancers, have decreased over the last several years for men and women, according to a report from the North American Association of Central Cancer Registries. Liver cancers are increasing, however, likely because of higher rates of hepatitis C, according to researcher Recinda Sherman. Reuters (3/30)
Legal & Regulatory
Supreme Court declines case challenging IPAB
The Supreme Court will not hear a lawsuit challenging the legitimacy of the Medicare Independent Payment Advisory Board, a panel set up under the Affordable Care Act that would convene and recommend Medicare changes to Congress only if costs rise by a certain amount. The lawsuit also challenged the ACA's individual mandate. Reuters (3/30)
Share: LinkedInTwitterFacebookGoogle+Email
High court rules against providers in Medicaid lawsuit
Health care providers are incidental beneficiaries of Medicaid and as such have no right to sue for higher reimbursement rates, the Supreme Court said in a 5-4 ruling. Dan Ehlke, an assistant professor of health policy at SUNY Downstate Medical Center School of Public Health, said the decision "further reinforces a long-running trend toward ever-lower Medicaid reimbursement that, at some point, will reach a level that is untenable." MedPage Today (free registration) (3/31), Bloomberg (3/31)
Share: LinkedInTwitterFacebookGoogle+Email
Practice News
Doctors express concerns about stage 3 meaningful use proposed rule
A poll conducted by QuantiaMD found that 71% of surveyed doctors could meet the measures in the proposed rule for stage 3 of meaningful use, but only 38% of respondents are happy with the proposed rule. The survey found that 53.33% of participants said patient engagement would be the hardest measure to meet, followed by care coordination at 42.67%. Healthcare Informatics online (3/27)
Share: LinkedInTwitterFacebookGoogle+Email
Business & Market Trends
Hepatitis C drug prices strain Medicare Part D
New hepatitis C drugs cost Medicare $4.5 billion last year, compared with about $286 million for hepatitis C drugs in 2013, federal data show. Part D plans also spent $157 million on older hepatitis C drugs last year. The Washington Post (tiered subscription model)/ProPublica (3/29)
Share: LinkedInTwitterFacebookGoogle+Email
Patient's Perspective
Survey: Patients still want direct interaction with physicians
A Nuance survey of 3,000 patients from the U.S., U.K. and Germany found that while 97% are comfortable with health care technology, 68% of U.S. and U.K. patients expected physicians to make eye contact and offer a handshake during their face-to-face interactions. German patients cited the importance of eye contact and handshake, but said privacy was the most important for them. BeckersHospitalReview.com (3/30)
Share: LinkedInTwitterFacebookGoogle+Email
ACG News
New video presentations added to the ACG Education Universe
More than 40 new videos have been added to the ACG Education Universe, with many offering CME. Ten video presentations feature leading experts highlighting recent clinical guidelines on GERD, achalasia, EoE and eosinophilia, anorectal disorders and more. In addition, several of the guidelines also have accompanying audio podcasts with one of the guideline authors. Browse the ACG Education Universe. For a list of guidelines, related video presentations and audio podcasts, visit this page.
Share: LinkedInTwitterFacebookGoogle+Email
Bringing fecal transplant to your practice: How to do it
Leading expert Colleen R. Kelly, M.D., FACG, discusses practical issues related to the performance of fecal transplantation in practice during the Gastrointestinal Endoscopy session offered at the ACG Eastern Regional Postgraduate Course on June 13 and 14 at the Seaport Hotel & World Trade Center in Boston. Also during the session, John R. Saltzman, M.D., FACG, analyzes the risks and benefits of performing endoscopy on patients taking anti-coagulants, and Laith Jamil, M.D. and Vivek Kaul, M.D., FACG, will present video cases that review management strategies for large polyps and summarize techniques used during performance of ERCP, EUS and other procedures. Gastrointestinal Endoscopy is just one of seven sessions offered. In addition, you'll find four breakout sessions and hands-on sessions to choose from, plus a special lunch presentation on hepatitis C. Prior to the start of the Regional Course, ACG will offer Hepatitis School on Friday, June 12. Registration is open. Learn more about Hepatitis School and the Eastern Regional Postgraduate Course. Register today.
Share: LinkedInTwitterFacebookGoogle+Email
The most common way people give up their power is by thinking they don't have any."
-- Alice Walker,
Share: LinkedInTwitterFacebookGoogle+Email
Learn more about ACG® ->Homepage | Meetings | Resources | National Affairs
Digestive Health Resources
Subscriber Tools
Please contact one of our specialists for advertising opportunities, editorial inquiries, job placements, or any other questions.
Editor:  Tara Rosenzweig
Advertising:  Hillary Batchelder
  P: 202.407.7803

Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2015 SmartBrief, Inc.®
Privacy policy |  Legal Information